Skip to main content
. Author manuscript; available in PMC: 2014 May 24.
Published in final edited form as: Neurosci Lett. 2013 Mar 21;543:157–162. doi: 10.1016/j.neulet.2013.03.014

Fig. 2.

Fig. 2

12S-hydroxy-1,12-pyrazolinominocycline (PMIN; 0.95, 9.50 or 95.00 μM) inhibits LPS-induced prostaglandin (PG) E2 microglial production, as assessed by enzyme immunoassay. PMIN (or vehicle) was added to the cell media 30 min prior to LPS (10 ng/ml, 24-h incubation). Data are expressed as mean ± S.E.M. ** p < 0.01 compared with LPS control.